Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Gefitinib therapy can cause unusual hair growth on the nose.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Isaria cicadae Miquel rice fermentation extract helps heal wounds and regenerate hair follicles.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

EREG therapy may help treat hair loss by promoting hair growth.

Endogenous EGF helps heal second-degree scald wounds faster.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Injury boosts normal skin cell growth, reducing cancer cell advantage.